Simulations Plus investor relations material

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.  Through an extensive network of consultants, SPI provides insight in addition to the science of molecular modeling services and expert testimony in litigation relating to molecular property analysis, from both a scientific and business perspective. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.